COMMUNIQUÉS West-GlobeNewswire

HEXO annonce le dépôt d’un prospectus préalable de base provisoire
09/11/2018
GATINEAU, Québec, 09 nov. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO) a annoncé le dépôt d’un prospectus préalable de base simplifié provisoire auprès des autorités de réglementation en [...]
MacroGenics Reports Presentation of Clinical Data at 33rd Annual SITC Meeting
09/11/2018
Enoblituzumab + pembrolizumab combination study data reported: ORRs in anti-PD-1/PD-L1 naïve SCCHN and NSCLC cohorts benchmarked favorably vs. approved anti-PD-1 agents Interim data from Phase 1 dose expansion study of [...]
Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update
09/11/2018
SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2018 and a business update. Dr. Dennis J. Carlo [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
09/11/2018
Conference Call Scheduled for Monday, November 12 th at 11:30 AM EST NORTHVALE, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]
Atrion Reports Third Quarter Results
09/11/2018
ALLEN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2018 revenues totaled $39.3 million, up from $37.9 million for the same [...]
Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights
09/11/2018
Investor Conference Call on Monday, November 12 th at 10:00 a.m. ET NEW YORK and CLEVELAND, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company [...]
Asterias Biotherapeutics Reports Third Quarter Results
09/11/2018
Clinical Programs Continue to Progress Recent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating Expenses Recently Announced Definitive Merger Agreement with BioTime Creates [...]
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
09/11/2018
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Corporate Development and IT & Database Administrator NEWTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc [...]
athenahealth Reports Third Quarter Fiscal Year 2018 Results
09/11/2018
Company Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for [...]
OPKO Health Reports Third Quarter 2018 Financial Results
09/11/2018
Conference Call begins today at 4:15 p.m. Eastern Time MIAMI , Nov. 09, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended September 30, [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
09/11/2018
BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in November. David Roberts, President, is scheduled to present at [...]
TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting
09/11/2018
Initial data from AMBER trial of TSR-022 (anti-TIM-3) in combination with TSR-042 (anti-PD-1) demonstrated clinical activity in patients who have progressed following anti-PD-1 treatment TSR-042 monotherapy demonstrated [...]
Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium
09/11/2018
Initiating Phase 1 ATTCK-34-01 Trial in HER2+ Advanced Cancers by Year-End CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on [...]
Adamas to Present at Three November Investor Conferences
09/11/2018
EMERYVILLE, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Unilever and Bio-on work together to reduce environmental impact in the Personal Care sector
09/11/2018
Rome (Italy), 9 November 2018 - Unilever and Bio-on announce the start of a strategic partnership to develop, produce and sell personal hygiene and care products that guarantee a smaller or no environmental impact. [...]
Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization
09/11/2018
MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care ("POC") diagnostics company focused on infectious diseases, today announced the receipt of U.S. Food and [...]
Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group
09/11/2018
DALLAS, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications, presented initial data [...]
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019
09/11/2018
DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at [...]

Pages